BioAtla, Inc. (BCAB) Tops Q1 EPS by 13c
BioAtla, Inc. (NASDAQ: BCAB) reported Q1 EPS of ($0.26), $0.13 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.
BioAtla, Inc. (NASDAQ: BCAB) reported Q1 EPS of ($0.26), $0.13 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.